Impax Asset Management Group PLC Bristol Myers Squibb CO Transaction History
Impax Asset Management Group PLC
- $14.9 Billion
- Q1 2025
A detailed history of Impax Asset Management Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Impax Asset Management Group PLC holds 131,431 shares of BMY stock, worth $6.29 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
131,431
Previous 148,246
11.34%
Holding current value
$6.29 Million
Previous $8.38 Million
4.4%
% of portfolio
0.05%
Previous 0.04%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,810Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.16 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.59 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.17 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.54 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.18 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...